1 |
As |
- |
- |
- |
- |
046 [6] 46, 53, 96, 97, 215, 271 💬 |
2 |
Calcium |
Calcium |
- |
- |
- |
006 [27] 6 , 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 265, 274, 298, 299 💬 |
3 |
Calcium gluconate |
Calcium |
[1] D00935 D00935 💬 |
- |
- |
214 [3] 214, 215, 235 💬 |
4 |
Coenzyme q10 |
Ubidecarenone |
[1] D01065 D01065 💬 |
- |
- |
002 [12] 2 , 5 , 6 , 8 , 10, 18, 46, 57, 113, 193, 214, 215 💬 |
5 |
Cpx |
- |
- |
- |
- |
215 [2] 215, 299 💬 |
6 |
Device: cellvizio 100 series system with confocal miniprobes |
- |
- |
- |
- |
215 [1] 215 💬 |
7 |
Dexmedetomidine |
Dexmedetomidine |
[2] D00514 D00514, D01205 D01205 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
002 [12] 2 , 4 , 6 , 21, 34, 46, 70, 113, 212, 215, 226, 280 💬 |
8 |
Dobutamin |
Dobutamine |
[4] D00632 D00632, D03879 D03879, D03880 D03880, D03881 D03881 💬 |
ADRB1 [1] ADRB1 💬 |
Adrenergic signaling in cardiomyocytes [10] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
215 [1] 215 💬 |
9 |
Dobutamine |
Dobutamine |
[4] D00632 D00632, D03879 D03879, D03880 D03880, D03881 D03881 💬 |
ADRB1 [1] ADRB1 💬 |
Adrenergic signaling in cardiomyocytes [10] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
057 [3] 57, 58, 215 💬 |
10 |
Eplerenone |
Eplerenone |
[1] D01115 D01115 💬 |
NR3C2 [1] NR3C2 💬 |
Aldosterone-regulated sodium reabsorption [1] Aldosterone-regulated sodium reabsorption |
075 [4] 75, 113, 210, 215 💬 |
11 |
Fentanyl |
Fentanyl |
[2] D00320 D00320, D01399 D01399 💬 |
OPRM1 [1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
046 [4] 46, 70, 215, 231 💬 |
12 |
Fentanyl (high dose) |
Fentanyl |
[2] D00320 D00320, D01399 D01399 💬 |
OPRM1 [1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
215 [1] 215 💬 |
13 |
Fentanyl (low dose) |
Fentanyl |
[2] D00320 D00320, D01399 D01399 💬 |
OPRM1 [1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
215 [1] 215 💬 |
14 |
Fentanyl (low dose) + dexmedetomidine |
Dexmedetomidine |
[4] D00320 D00320, D00514 D00514, D01205 D01205, D01399 D01399 💬 |
ADRA2A [4] ADRA2A, ADRA2B, ADRA2C, OPRM1 💬 |
Estrogen signaling pathway [4] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
215 [1] 215 💬 |
15 |
Fluorescite |
- |
- |
- |
- |
215 [1] 215 💬 |
16 |
Gradient |
- |
- |
- |
- |
058 [4] 58, 86, 149, 215 💬 |
17 |
Ketamine |
Ketamine |
[2] D00711 D00711, D08098 D08098 💬 |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
013 [5] 13, 70, 113, 156, 215 💬 |
18 |
Losartan |
Losartan |
[2] D00357 D00357, D08146 D08146 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬 |
19 |
Losartan potassium |
Losartan |
[3] D00357 D00357, D08146 D08146, D08403 D08403 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
036 [5] 36, 98, 167, 179, 215 💬 |
20 |
Other: dobutamine |
Dobutamine |
[4] D00632 D00632, D03879 D03879, D03880 D03880, D03881 D03881 💬 |
ADRB1 [1] ADRB1 💬 |
Adrenergic signaling in cardiomyocytes [10] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
215 [1] 215 💬 |
21 |
Other: transthoracic echocardiography at rest, during plr, hg and cpx (including blood gas analysis in both groups). additionally fallot patients will undergo routine blood testings. |
- |
- |
- |
- |
215 [1] 215 💬 |
22 |
Potassium |
Potassium |
[1] D08403 D08403 💬 |
- |
- |
036 [10] 36, 46, 66, 67, 98, 115, 167, 179, 215, 235 💬 |
23 |
Procedure: b-lines se |
- |
- |
- |
- |
058 [3] 58, 86, 215 💬 |
24 |
Procedure: coronary flow reserve se |
- |
- |
- |
- |
058 [3] 58, 86, 215 💬 |
25 |
Procedure: diastolic function se |
- |
- |
- |
- |
058 [3] 58, 86, 215 💬 |
26 |
Procedure: left ventricular contractile reserve se |
- |
- |
- |
- |
058 [3] 58, 86, 215 💬 |
27 |
Procedure: left ventricular outflow tract gradient se |
- |
- |
- |
- |
058 [3] 58, 86, 215 💬 |
28 |
Procedure: mitral regurgitation se |
- |
- |
- |
- |
058 [3] 58, 86, 215 💬 |
29 |
Procedure: pulmonary hemodynamics se |
- |
- |
- |
- |
058 [3] 58, 86, 215 💬 |
30 |
Procedure: tof repair with trans-annular patch vs preservation of pv |
- |
- |
- |
- |
215 [1] 215 💬 |
31 |
Pv |
- |
- |
- |
- |
013 [3] 13, 97, 215 💬 |
32 |
Recombinant human brain natriuretic peptide (rhbnp) |
- |
- |
- |
- |
215 [1] 215 💬 |
33 |
Sodium citrate |
Sodium citrate |
[2] D01781 D01781, D05855 D05855 💬 |
- |
- |
067 [4] 67, 214, 215, 235 💬 |
34 |
Tranexamic acid |
Tranexamic acid |
[1] D01136 D01136 💬 |
PLG [1] PLG 💬 |
Complement and coagulation cascades [4] Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection |
046 [5] 46, 70, 215, 227, 288 💬 |